Nevertheless, the mechanism for the role of Miro1 that was identified here may provide insight into strategies that focus on pharmacologically restoring the role of mitochondrial quality control mechanisms to treat inflammatory lung conditions, such as COPD. The gene discussed is RHOT1; the disease is chronic obstructive pulmonary disease.